Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1701卷 / 1期

关键词：

D O I：

10.1007/s40278-018-45847-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[1] Adalimumab/certolizumab-pegolDevelopment of anti-drug antibodies: 2 case reports
[J]. Reactions Weekly, 2020, 1800 (1) : 16 - 16
[2] Adalimumab/infliximabAnaphylactic reaction and presence of anti-drug antibodies : 2 case reports
[J]. Reactions Weekly, 2021, 1863 (1) : 18 - 18
[3] InfliximabDevelopment of anti-drug antibodies and paradoxical skin reactions in the form of psoriasis vulgaris and pyoderma gangrenosum: 16 case reports
[J]. Reactions Weekly, 2021, 1836 (1) : 412 - 412
[4] AntirheumaticsDevelopment of anti-drug antibodies: 11 case reports
[J]. Reactions Weekly, 2018, 1705 (1) : 42 - 42
[5] Adalimumab/methotrexateLack of efficacy and development of anti-drug antibodies : case report
[J]. Reactions Weekly, 2018, 1724 (1) : 18 - 18
[6] Adalimumab/etanerceptNeutralising anti-drug antibodies and lack of efficacy: case report
[J]. Reactions Weekly, 2021, 1844 (1) : 19 - 19
[7] Infliximab/methotrexatePneumonitis and development of anti-drug antibodies: 2 case reports
[J]. Reactions Weekly, 2023, 1960 (1) : 241 - 241
[8] NatalizumabDevelopment of anti-drug antibodies and treatment failure: 6 case reports
[J]. Reactions Weekly, 2022, 1897 (1) : 286 - 286
[9] Adalimumab/etanercept/infliximabDevelopment of autoantibodies: 37 case reports
[J]. Reactions Weekly, 2015, 1537 (1) : 16 - 16
[10] Factors that may influence the development of anti-drug antibodies to adalimumab
Reinisch, W.
Rauter, I.
Chen, L.
Gessner, M.
Fanjiang, G.
[J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S429 - S430

← 1 2 3 4 5 →